CRISPR/Cas9-Mediated Treatment Ameliorates the Phenotype of the Epidermolytic Palmoplantar Keratoderma-like Mouse

CRISPR/Cas9 has been confirmed as a distinctly efficient, simple-to-configure, highly specific genome-editing tool that has been used to treat monogenetic disorders. Epidermolytic palmoplantar keratoderma (EPPK) is a common autosomal dominant keratin disease resulting from dominant-negative mutation...

Descripción completa

Detalles Bibliográficos
Autores principales: Luan, Xiao-Rui, Chen, Xiao-Ling, Tang, Yue-Xiao, Zhang, Jin-Yan, Gao, Xiang, Ke, Hai-Ping, Lin, Zhao-Yu, Zhang, Xian-Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6023945/
https://www.ncbi.nlm.nih.gov/pubmed/30195761
http://dx.doi.org/10.1016/j.omtn.2018.05.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6023945/
https://www.ncbi.nlm.nih.gov/pubmed/30195761
http://dx.doi.org/10.1016/j.omtn.2018.05.005

Ejemplares similares